{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:07:54Z","timestamp":1776370074567,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011057","name":"National Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ab.2025.115787","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:10:41Z","timestamp":1738347041000},"page":"115787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies"],"prefix":"10.1016","volume":"700","author":[{"given":"Sheila","family":"Ch\u00e1vez-Vald\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana K.","family":"Marichal-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahima","family":"Chac\u00f3n-Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Mart\u00ednez-Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivaldo","family":"G\u00f3mez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lismary","family":"\u00c1vila-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"V\u00e1zquez-Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Gonz\u00e1lez-Formental","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Freyre-Corrales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edelgis","family":"Coizeau-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-6501","authenticated-orcid":false,"given":"Gilda","family":"Lemos-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ab.2025.115787_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ab.2025.115787_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbt.2022.08.002","article-title":"An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen","volume":"72","author":"Limonta-Fern\u00e1ndez","year":"2022","journal-title":"N. Biotech."},{"key":"10.1016\/j.ab.2025.115787_bib4","article-title":"Cuban Abdala vaccine: effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study","author":"M\u00e1s-Bermejo","year":"2022","journal-title":"Lancet. Reg. Health Am."},{"key":"10.1016\/j.ab.2025.115787_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101383","article-title":"Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)","volume":"46","author":"Hern\u00e1ndez-Bernal","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"63","key":"10.1016\/j.ab.2025.115787_bib6","article-title":"ISMAELILLO Clinical Trial Group. Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1\/2 clinical trial (ISMAELILLO study)","volume":"18","author":"Cinza-Est\u00e9vez","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"21","key":"10.1016\/j.ab.2025.115787_bib7","article-title":"ABDALA Research Group. A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)","volume":"5","author":"Hern\u00e1ndez-Bernal","year":"2023","journal-title":"Lancet. Reg. Health Am."},{"issue":"9","key":"10.1016\/j.ab.2025.115787_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/vaccines12091001","article-title":"Safety and immunogenicity of the intranasal vaccine candidate Mambisa and the intramuscular vaccine Abdala used as booster doses for COVID-19 convalescents: a randomized phase 1-2 clinical trial","volume":"12","author":"Lemos-P\u00e9rez","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ab.2025.115787_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12033-007-0003-7","article-title":"Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies","volume":"36","author":"Mitsuda","year":"2007","journal-title":"Mol. Biotechnol."},{"issue":"7271","key":"10.1016\/j.ab.2025.115787_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bmj.321.7271.1237","article-title":"The importance of injecting vaccines into muscle","volume":"321","author":"Zuckerman","year":"2000","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.ab.2025.115787_bib11","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.vaccine.2023.05.011","article-title":"Advances in intranasal vaccine delivery: a promising non-invasive route of immunization","volume":"41","author":"Kehagia","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ab.2025.115787_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/vaccines12020191","article-title":"Vaccine strategies to elicit mucosal immunity","volume":"12","author":"Song","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ab.2025.115787_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14760584.2023.2268724","article-title":"Mucosal vaccination: onward and upward","volume":"22","author":"Tsai","year":"2023","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.ab.2025.115787_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1348905","article-title":"Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations","volume":"15","author":"Serwanga","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ab.2025.115787_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12936-017-2129-9","article-title":"Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity","volume":"16","author":"Knepper","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ab.2025.115787_bib16","series-title":"ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis","year":"2022"},{"key":"10.1016\/j.ab.2025.115787_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.112958","article-title":"Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies","volume":"490","author":"Kr\u00e4hling","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2025.115787_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15378-1","article-title":"Development of an in-house quantitative ELISA for the evaluation of different COVID-19 vaccines in humans","volume":"12","author":"Gdoura","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2025.115787_bib20","unstructured":"CECMED Resolution No. 40\/2014: Annex No.1 Good Practices for Drug Control Laboratories. Validation of Analytical Methods Edition 2 http:\/\/www.cecmed.cu\/reglamentacion\/aprobadas\/resolucion-cecmed-40 [Accessed 5 September, 2024]."},{"issue":"4","key":"10.1016\/j.ab.2025.115787_bib21","first-page":"316","article-title":"Correct use of percent coefficient of variation (%CV) formula for log-transformed data","volume":"6","author":"Canchola","year":"2017","journal-title":"MOJ Proteomics. Bioinform."},{"key":"10.1016\/j.ab.2025.115787_bib22","doi-asserted-by":"crossref","unstructured":"United States Pharmacopeia (50-4). General Chapter, \u27e81033\u27e9 Biological Assay Validation. USP-NF. Rockville, MD: United States Pharmacopeia. https:\/\/doi.org\/10.31003\/USPNF_M912_102010201_01.","DOI":"10.31003\/USPNF_M912_102010201_01"},{"key":"10.1016\/j.ab.2025.115787_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113160","article-title":"Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples","volume":"499","author":"Larsen","year":"2021","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.ab.2025.115787_bib24","first-page":"24","article-title":"Full validation of an ELISA for quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide","volume":"8","author":"P\u00e9rez-Bernal M","year":"2021","journal-title":"J. Appl. Biotech. Bioeng."},{"issue":"1","key":"10.1016\/j.ab.2025.115787_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12985-022-01768-4","article-title":"Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections","volume":"19","author":"Luo J","year":"2022","journal-title":"Virol. J."},{"key":"10.1016\/j.ab.2025.115787_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.ab.2025.115787_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249499","article-title":"Human IgG and IgA responses to COVID-19 mRNA vaccines","volume":"16","author":"Wisnewski","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2025.115787_bib28","first-page":"12","article-title":"Anti-SARS-CoV-2 immunoglobulin isotypes, and neutralization activity against viral variants, according to BNT162b2-vaccination and infection history","author":"Tarkowski","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ab.2025.115787_bib29","article-title":"Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection","volume":"14","author":"Abril","year":"2024","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.ab.2025.115787_bib30","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki. ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269725000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269725000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:59:38Z","timestamp":1740484778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269725000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"alternative-id":["S0003269725000247"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2025.115787","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2025.115787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115787"}}